STATE STREET CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$3,299,409
+11.0%
1,126,078
+8.4%
0.00%
Q2 2023$2,972,341
+45.6%
1,039,280
+57.3%
0.00%
Q1 2023$2,041,857
-1.5%
660,795
-32.7%
0.00%
Q4 2022$2,071,956
+51.8%
981,970
+134.6%
0.00%
Q3 2022$1,365,000
+1.7%
418,613
+0.1%
0.00%
Q2 2022$1,342,000
-21.2%
418,042
+73.3%
0.00%
Q1 2022$1,703,000
+237.2%
241,203
+246.2%
0.00%
Q4 2021$505,00069,6770.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders